Cargando…
How Does the Canadian General Public Rate Moderate Alzheimer's Disease?
Objectives. The objectives of this study were to elicit health utility scores for moderate Alzheimer's disease (AD) using members of the general public. Methods. Five-hundred Canadians were chosen randomly to participate in a telephone interview. The EQ-5D was administered to estimate the healt...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250621/ https://www.ncbi.nlm.nih.gov/pubmed/22229093 http://dx.doi.org/10.4061/2011/682470 |
_version_ | 1782220493924859904 |
---|---|
author | Tarride, Jean-Eric Oremus, Mark Pullenayegum, Eleanor Clayton, Natasha Raina, Parminder |
author_facet | Tarride, Jean-Eric Oremus, Mark Pullenayegum, Eleanor Clayton, Natasha Raina, Parminder |
author_sort | Tarride, Jean-Eric |
collection | PubMed |
description | Objectives. The objectives of this study were to elicit health utility scores for moderate Alzheimer's disease (AD) using members of the general public. Methods. Five-hundred Canadians were chosen randomly to participate in a telephone interview. The EQ-5D was administered to estimate the health utility score for respondents' current health status (i.e., no AD) and for a hypothetical moderate AD health state. Regression analyses were conducted to explain the perceived utility decrement associated with AD. Results. The mean age of the respondents was 51 years, 60% were female, and 42% knew someone with AD. Respondents' mean EQ-5D scores for their current health status and a hypothetical moderate AD were 0.873 (SD: 0.138) and 0.638 (SD: 0.194), respectively (P < 0.001). Age, gender, and education were significant factors explaining this decrement in utility. Conclusion. Members of the general public may serve as an alternative to patients and caregivers in the elicitation of health-related quality of life in AD. |
format | Online Article Text |
id | pubmed-3250621 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | SAGE-Hindawi Access to Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-32506212012-01-06 How Does the Canadian General Public Rate Moderate Alzheimer's Disease? Tarride, Jean-Eric Oremus, Mark Pullenayegum, Eleanor Clayton, Natasha Raina, Parminder J Aging Res Research Article Objectives. The objectives of this study were to elicit health utility scores for moderate Alzheimer's disease (AD) using members of the general public. Methods. Five-hundred Canadians were chosen randomly to participate in a telephone interview. The EQ-5D was administered to estimate the health utility score for respondents' current health status (i.e., no AD) and for a hypothetical moderate AD health state. Regression analyses were conducted to explain the perceived utility decrement associated with AD. Results. The mean age of the respondents was 51 years, 60% were female, and 42% knew someone with AD. Respondents' mean EQ-5D scores for their current health status and a hypothetical moderate AD were 0.873 (SD: 0.138) and 0.638 (SD: 0.194), respectively (P < 0.001). Age, gender, and education were significant factors explaining this decrement in utility. Conclusion. Members of the general public may serve as an alternative to patients and caregivers in the elicitation of health-related quality of life in AD. SAGE-Hindawi Access to Research 2011 2011-12-20 /pmc/articles/PMC3250621/ /pubmed/22229093 http://dx.doi.org/10.4061/2011/682470 Text en Copyright © 2011 Jean-Eric Tarride et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Tarride, Jean-Eric Oremus, Mark Pullenayegum, Eleanor Clayton, Natasha Raina, Parminder How Does the Canadian General Public Rate Moderate Alzheimer's Disease? |
title | How Does the Canadian General Public Rate Moderate Alzheimer's Disease? |
title_full | How Does the Canadian General Public Rate Moderate Alzheimer's Disease? |
title_fullStr | How Does the Canadian General Public Rate Moderate Alzheimer's Disease? |
title_full_unstemmed | How Does the Canadian General Public Rate Moderate Alzheimer's Disease? |
title_short | How Does the Canadian General Public Rate Moderate Alzheimer's Disease? |
title_sort | how does the canadian general public rate moderate alzheimer's disease? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250621/ https://www.ncbi.nlm.nih.gov/pubmed/22229093 http://dx.doi.org/10.4061/2011/682470 |
work_keys_str_mv | AT tarridejeaneric howdoesthecanadiangeneralpublicratemoderatealzheimersdisease AT oremusmark howdoesthecanadiangeneralpublicratemoderatealzheimersdisease AT pullenayegumeleanor howdoesthecanadiangeneralpublicratemoderatealzheimersdisease AT claytonnatasha howdoesthecanadiangeneralpublicratemoderatealzheimersdisease AT rainaparminder howdoesthecanadiangeneralpublicratemoderatealzheimersdisease |